Stephanie T. Schmidt
Venture FellowStephanie works at the intersection of AI, deep technology, and venture investing. At ETV, she is building Radar AI, the fund’s AI-powered corporate venture intelligence platform, along with the broader AI operating stack that supports sourcing, diligence, and investor relationships.
She is the founder and CEO of Health Wayfinder, a health technology company harnessing frontier AI capabilities to empower patients. With health systems facing a persistent tension between quality care and efficiency, her work gives patients the ability to act on their own health information.
She is also a Nonresident Scholar at Rice’s Baker Institute for Public Policy, where she focuses on the impact of AI on healthcare. Her recent policy briefs have examined the growing health data economy and closing the patient comprehension gap using AI.
Stephanie holds a Ph.D. and M.S. in Bioengineering from Stanford University, where she was a Hertz Foundation Fellow in the laboratory of Stephen Quake, and a B.S. in Bioengineering, summa cum laude, from Rice University. Her research has been published in Nature and in the Proceedings of the National Academy of Sciences. She is a Siebel Scholar and an Accel Innovation Scholar, and is pursuing an Executive MBA at Rice’s Jones Graduate School of Business.













